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ABSTRACT
This study was conducted to assess the relative contribution of iron, folate, and B12 deficiency to anaemia
in pregnant women in sub-Saharan Africa. In total, 146 pregnant women, who attended two antenatal
clinics in Gombe, Nigeria, were recruited into the study. The majority (54%) of the women were in the
third trimester. Blood samples were obtained for determination of haematocrit and for measurement of
serum iron, total iron-binding capacity, ferritin, folate, vitamin B12, and homocysteine. Malaria was
present in 15 (9.4%) women. Based on a haemoglobin value of <105 g/L, 44 (30%) women were classi-
fied as anaemic. The major contributing factor to anaemia was iron deficiency based on the serum con-
centration of ferritin (<10 ng/mL). The mean homocysteine concentration for all subjects was 14.1 µmol/L,
and homocysteine concentrations were inversely correlated with concentrations of folate and vitamin
B12. The serum homocysteine  increased markedly at serum vitamin B12 levels below 250 pmol/L. The
most common cause of anaemia in the pregnant women in northern Nigeria was iron deficiency, and
the elevated concentrations of homocysteine were most likely due to both their marginal folate and vita-
min B12 status. 
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INTRODUCTION
Anaemia in pregnancy is a global problem and is asso-
ciated with increased maternal morbidity and mortality
(1). Anaemia in pregnancy is more common in develop-
ing countries than in developed countries. In the USA,
less than 30% of pregnant women develop anaemia,
whereas the prevalence rates in Africa, Asia, and Latin
America range from 35% to 75% (2,3). Maternal deaths
from anaemia range from 34 per 100,000 livebirths
in Nigeria to as high as 194 per 100,000 livebirths in
Pakistan (1,4). 
In 1987, the United Nations Children's Fund and re-
presentatives from 45 countries launched the Safe Mother-
hood Initiative (SMI) for reducing maternal mortality
worldwide by 50% by 2000 (5). One of the major goals
of the Initiative was to eradicate anaemia during preg-
nancy. Results of recent studies of maternal morbidity
and mortality in sub-Saharan Africa showed that anae-
mia continues to be a major contributing factor to mater-
nal mortality in this part of the world (6-8). 
In developing countries, the cause of anaemia during
pregnancy is multi-factorial and includes nutritional defi-
ciencies of iron, folate, and vitamin B12 and also para-
sitic diseases, such as malaria and hookworm. The rela-
tive contribution of each of these factors to anaemia du-
ring pregnancy varies greatly by geographical location, 
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season, and dietary practice. In sub-Saharan Africa, iron
and folate deficiencies are the most common causes of
anaemia in pregnant women (9-11). Vitamin B12 defi-
ciency may be an unrecognized contributor to anaemia
in this region of the world due to reliance of the popula-
tion on grains as dietary staples and low consumption
of foods of animal origin which are the primary source
of dietary vitamin B12. We have documented that approxi-
mately 10% of adolescent girls in Maidudguri, Nigeria,
had serum vitamin B12 levels, indicative of a deficiency
of this vitamin (12). 
The purposes of this cross-sectional study were to
determine the incidence of anaemia among pregnant
women attending typical antenatal clinics in northern
Nigeria and to inquire about the contribution of iron,
folate and vitamin B12 deficiencies to anaemia in these
women.  
MATERIALS AND METHODS
Subjects 
Across-sectional study of pregnant women who pre-
sented at two antenatal clinics (the Federal Medical Cen-
tre and the Specialist Hospital) in Gombe, Nigeria, was
conducted during June-August 2003, which corresponds
to the rainy season. These clinics are typical of antenatal
clinics elsewhere in northern Nigeria. The women were
inhabitants of the town of Gombe and villages that lie
within a 30-mile radius of the town. The study was limited
to healthy normotensive pregnant women with no history
of hypertension, proteinuria, or other complications of
pregnancy. Women with pre-eclampsia (systolic blood
pressure ≥140 mm Hg or diastolic blood pressure ≥90
mm Hg) and a positive urine protein (measured by dip-
stick) were excluded from the study. 
Asingle blood sample for biochemical analyses was
obtained from each subject who visited the antenatal cli-
nic during June-August 2003. Ahaematocrit was obtained
for each subject at the time of her visit to the antenatal
clinic. Informed consents were obtained from all the sub-
jects after describing the study, and its requirements
were given to them in English or their native language
(Hausa or Fulfulde) by a translator. At the time the blood
sample was drawn, information regarding gravidum,
parity, education, and use of supplements by the subjects
was recorded. Gestational age was estimated by both
using date of the last menstrual period and measuring
fundal height. The presence of malarial infection was
determined by microscopy using thick smears. Since
biochemical analyses were not completed until several
months after the blood samples were drawn, it was not 
possible to judicate administration of supplements on the
basis of specific nutrient deficiencies of iron, folate, or
vitamin B12. However, it is a standard procedure at these
two antenatal clinics to provide iron and folate supple-
ments to any pregnant woman whose haematocrit is in-
dicative of anaemia. 
The Human Research Review Committee of the Uni-
versity of New Mexico School of Medicine and the Ethics
Review Committee of the Federal Medical Centre, Gombe,
approved the study. 
Anthropometric measurements 
Age in years was self-reported. Weight was measured
using a battery-operated scale accurate to 0.5 kg, and
height was measured to within 0.25 cm using a portable
stadiometer. Mid-arm circumference was determined
using a tape (Creative Health Products, Plymouth, MI,
USA). Triceps skin-fold thickness was measured with
a body caliper (Caliper Company, Inc, Carson City, NV,
USA).  
Biochemical analyses 
Blood was obtained by venipuncture and collected into
trace metal-free vacutainer tubes containing EDTA
(Becton Dickinson, New Jersey, USA). After determin-
ing the haematocrit (packed cell volume), the plasma
fraction was obtained by centrifugation, aliquoted into
cryovials, and stored at -80 °C. Samples were transported
to Albuquerque, NM in the frozen state for analysis of
iron, total iron-binding capacity, ferritin, folate, vitamin
B12, and homocysteine.
Serum iron and unsaturated iron-binding capacity
were measured using the Ferrozine colorimetric assay
(Boehringer-Mannheim Diagnostics, Hitachi model 717,
Indianapolis, IN; detection limit 5 µg/dL and 10 µg/dL
respectively). Total iron-binding capacity was calculated
as the sum of serum concentration of iron and unsaturated
iron-binding capacity. The percentage of iron saturation
was calculated from the serum concentration of iron and
total iron-binding capacity. Plasma folate and vitamin
B12 were determined using a chemiluminescent im-
munological assay (Diagnostic Products Corporation,
Immulite 2000, Los Angeles, CA, USA; detection limit
0.3 ng/mL and 50 pg/mL respectively). Plasma homo-
cysteine was measured using a flouresence polariza-
tion immunological assay (Abbott Diagnostics, AxSYM
System®, Abbott Park, IL, USA; detection limit 0.8
µmol/L). Serum ferritin was measured using a che-
miluminescence assay (Beckman Diagnostics, Access
B, Fullerton, CA, USA; detection limit 0.2 ng/mL).  Anaemia in pregnant women in Nigeria 77
Statistical analysis
Unless otherwise indicated, results are expressed as the
mean±1 standard deviation. For those variables that
were not normally distributed, results are given as the
median followed by the range indicated in parentheses.
Parameters with a non-normal distribution were trans-
formed prior to statistical analyses. Descriptive statistics,
group comparisons, and correlation analyses were made
using the Number Cruncher statistical software (NCSS,
Kaysville, UT, USA). Ap value of 0.05 was considered
to be statistically significant.
RESULTS
Study population 
In total, 146 pregnant women were enrolled in the study.
Their anthropometric characteristics are summarized in
Table 1. Their mean age was 26.7 (range 15-45) years,
trimester of pregnancy with 5% (n=8) in the first tri-
mester and 41% (n=59) in the second trimester. Gravidum
ranged from 1 to 17 with a median of 5. Parity ranged
from 0 to 11 with a median of 3 children. Forty-two per-
cent of the subjects took iron supplements, 30% folate
supplements, and 33% multi-vitamins. Fifteen (9.4%)
women tested positive for malaria by microscopy of thick
blood smears at the time of the study. Approximately,
25% (n=37) of the women took malaria prophylaxis.
The majority (61%) reported having had no formal
education.
Biochemical analyses
Results of biochemical analysis are summarized in Table 2.
Because of the haemodilution that naturally occurs du-
ring pregnancy, the results of biochemical analyses are
grouped according to trimester. The mean concentration
of haemoglobin for the 146 subjects was 110 g/L, with
a range of 50 g/L to 180 g/L. Overall, 44 (32%) had a
Table 1. Anthropometric characteristics of pregnant women in Gombe, Nigeria
Parameter                              Trimester 1(n=8)                  Trimester 2 (n=59)                Trimester 3 (n=79)
Age (years) 23.0± 7.1* 26.7±6.4 27.5±6.0
Height (cm) 161± 5 159±68 160±6
Weight (kg) 62.1±14.7 61.5±12.7 63.9±11.6
MAC (cm) 25.3±4.3 26.2±3.9 26.2±3.4
TSF (mm) 15±7 18±8 20±6
Gestation (weeks) 8.2±3.6 21.4±3.5 32.5±3.1
Gravida 4 (1-10)† 5 (1-12) 5 (1-17)
Parity 0 (0-9) 3 (0-8) 4 (0-11)
*Mean±SD; †Median (range)
MAC=Mid-arm circumference; TSF=Triceps skin-fold thickness
Table 2.  Biochemical characteristics of pregnant women in Gombe
Parameter                            Trimester 1 (n=8)      Trimester 2 (n=59)     Trimester 3 (n=79)  Normal values 
in pregnancy
Haemoglobin (g/L) 116±18* 112±17 109±14 >105†
Haematocrit (%) 35±5.5 34±5.1 33±4.3 >31.5†
Iron (µg/dL) 101±31 104±52 99±44 47-160‡
TIBC (pg/mL) 421±98 427±83 466±82 348-591‡
Iron saturation (%) 26±11 26±14 22±13 10.2-34.0‡
Ferritin (ng/mL) 27.7 (7.8-94.6)* 22.3 (6.3-314) 16.4 (4.0-206) >10‡,>30¶
Folate (nmol/L) 17.9±7.9 17.3±8.4 18.3±9.5 >7.7‡
Vitamin B12 (pmol/L) 240±59 228±76 218±66 148-616‡
Homocysteine (µmol/L) 14.2±5.1 12.9±3.5 14.0±4.9 4-12**
*Mean±standard deviation; **Median (range); TIBC=Total iron-binding capacity; †World Health 
Organization; ‡Burtis CA, Ashwood ER. Tietz Fundamentals of clinical chemistry (13); ¶van den Broek et al.
Br J Haematol 1998;103:817-24 (14)
their mean height was 160.2 cm, and their mean weight
was 62.8 kg. The majority (n=79, 54%) were in the third
haemoglobin concentration below 105 g/L, the cut-off
for anaemia established by the World Health Organiza-78 J Health Popul Nutr Mar 2007 VanderJagt DJ et al.
tion (4). The lowest mean concentration
of haemoglobin (109 g/L) was seen in wo-
men in the third trimester. However, there
was no statistically significant difference
in haemoglobin levels by trimester. Al-
though the total iron-binding capacity in-
creased significantly between the second
and the third trimester, there was no dif-
ference in serum concentration of iron,
percentage of transferrin saturation, or
ferritin concentration among  trimesters.
Twenty seven (18%) women had a se-
rum ferritin concentration of <10 ng/mL,
a level which is considered indicative of
iron deficiency in non-pregnant women.
Sixteen (20%) women in their third tri-
mester had ferritin levels below 10 ng/mL,
and 10 (16%) subjects had ferritin levels
below 10 ng/mL in their second trimester.
In an investigation of parameters used for
screening iron status in pregnant women,
van den Broek and co-workers (14) deter-
mined that a ferritin value of 30 ng/mL
or less was the best indicator of iron defi-
ciency in pregnant women when using
a stained marrow biopsy for validation.
Applying a cut-off of 30 ng/mL for iron
deficiency in the present study, 64% (n=
94) of the subjects were classified as iron-
deficient__33 (35%) in the second trimester
and 57 (61%) in the third trimester.
The serum concentrations of folate and
vitamin B12 of the pregnant women in each
trimester are shown in Table 2. The mean
concentration of folate for the 146 subjects
was 17.9 nmol/L. Only 13 women had a
serum concentration of folate below 7.7
nmol/L, a concentration that is at the lower
end of normal for folate. There were no dif-
ferences in the serum concentrations of fo-
late among groups. The mean concentra-
tion of vitamin B12 for the subjects was
223 pmol/L, which is above the cut-off of
148 pmol/L for deficiency. However, 15
(9%) of the women had a vitamin B12 con-
centration below this cut-off. There were no
significant differences in the mean concen-
trations of vitamin B12 based on trimester. 
Homocysteine can be elevated in se-
rum as the result of either folate or vitamin
B12 deficiency. Eighty-eight (55%) women
had a serum concentration of homocysteine
above 12 µmol/L, and the homocysteine levels did not differ by trimester.
Significant negative relationships with homocysteine were obtained for
both folate (Fig. 1) and vitamin B12 (Fig. 2). The relationship between
homocysteine and folate was best described by a linear equation
Fig. 1.  Relationship between serum concentrations of homocysteine
and serum concentrations of folate in pregnant women in
northern Nigeria  (r=0.24, p=0.003)
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Fig. 2.  Relationship between serum concentrations of homocysteine
and serum concentrations of vitamin B12 in pregnant wo-
men in northern Nigeria (r=0.41, p<0.001)
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(Fig. 1, r=0.24, p=0.003), whereas the relationship between homo-
cysteine and vitamin B12 was best described by non-linear equation in
which serum homocysteine concentrations increased markedly below
250 pmol/L (Fig. 2, r=0.41, p<0.001).  Anaemia in pregnant women in Nigeria 79
Subjects were next grouped according to haemoglo-
bin level (<105 and ≥105 g/L), and the gestational age-
adjusted means for the biochemical parameters are shown
in Table 3. The only biochemical parameter besides hae-
to anaemia in these pregnant women. Using a multiple
regression model which included ferritin, folate, vitamin
B12, and gestational age as the independent variables,
we found that only gestational age significantly corre-
lated with haemoglobin concentration. 
Twenty-two women with a haemoglobin level of
<105 g/Ltook iron supplements, 13 took folate supple-
ments, and 9 took both iron and folate supplements.
Only three anaemic women tested positive for malaria
(Table 4). Malaria was detected in 22 % of the non-
anaemic women.                 
DISCUSSION
In Gombe, Nigeria, and its environs, most prenatal care
is provided collectively by  the Federal Medical Centre,
a tertiary-care centre, and the Specialist Hospital which
serves patients from a broad range of socioeconomic
levels. The goals of this study were to determine the pre-
valence of anaemia and to examine the contributions of
iron, folate and vitamin B12 status to anaemia in preg-
nant women residing in this region. Our main finding
was that 30% of the pregnant women were anaemic,
using the WHO cut-off haemoglobin concentration of
105 g/L. The most common deficiency relating to anaemia
in these women was iron. 
This finding was not unexpected, since the diets of
the population in the region are heavily reliant on grains,
such as millet and sorghum, that contain large amounts
of phytates which are known to interfere with the intes-
tinal uptake of iron and other trace minerals, such as zinc
and calcium. Requirements of iron during pregnancy are
high, and it is difficult to meet the requirements through
diet alone.  Therefore, maintaining iron balance during
pregnancy is dependent on maternal iron stores. 
To better understand the aetiology of anaemia in our
study population, we determined the proportion of anae-
mic and non-anaemic women who were deficient in iron
(ferritin <30 ng/mL), folate (<7.7 nmol/L), or vitamin
B12 (<148 pmol/L). The greatest distinction between the
anaemic and the non-anaemic subjects was in the serum
ferritin level: 27% of the anaemic women had serum 
Table 3. Biochemical values for women with haemo-
globin values < or ≥105 g/L
Parameter (mean±SD)
Haemoglobin (g/L)
<105 (n=44)   >105 (n=102)
Haemoglobin 93.9 (1.6) 117 (1.1)*
Haematocrit (%) 28.3 (0.49) 35.4 (0.32)*
Iron (µg/dL) 89 (7.0) 106 (4.6)**
TIBC (pg/mL) 453 (12.5) 446 (8.2)
Iron saturation (%) 22 (2.0) 25 (1.3)
Ferritin (ng/mL) 34.1 (5.9) 31.9 (3.9)
Folate (nmol/L) 15.9 (1.37) 18.7 (0.89)
Vitamin B12 (pmol/L) 209 (10.5) 230 (6.9)
Homocysteine (µmol/L) 14.1 (0.66) 13.3 (0.43)
*p<0.001; **p=0.04
TIBC=Total iron-binding capacity
Table 4. Number and percentages of pregnant women with biochemical values indicative of deficiency
Parameter
Haemoglobin  <105 g/L (n=44)                Haemoglobin >105 g/L (n=102)
No.                        %                           No.                            %
Ferritin (<10 ng/mL) 12 27 15 15
(<30 ng/mL) 33 75 61 42
Folate   (<7.7 nmol/L) 6 14 7 7
Vitamin B12 (<148 pmol/L) 4 9 11 11
Malaria-positive 3 7 12 12
moglobin concentration and haematocrit that differed
between the two groups was serum iron. The anaemic
subjects had a mean gestational age-adjusted ferritin
concentration of 13.5 ng/mL compared to 22.3 ng/mL
for the non-anaemic women. 
Twelve (24%) of the 44 women who were classified as
anaemic based on a haemoglobin level below 105 g/L
had a serum concentration of ferritin below 10 ng/mL,
and 33 (75%) had a serum concentration of ferritin below
30 ng/mL(Table 4). Of the subjects with anaemia, 27%
had low ferritin levels, 14% had a sub-normal folate con-
centration, and 9% had a vitamin B12 concentration of
<148 pmol/L. These data suggest that iron deficiency
was the major cause of anaemia among our study women.
Of the non-anaemic subjects (n=102), 15% had a sub-
normal ferritin level, 11% had low folate levels (<7.7
nmol/L), and 7% had a serum vitamin B12 level indica-
tive of a deficiency of this vitamin. Although more of
the anaemic subjects in our study had evidence of iron
deficiency based on serum ferritin levels, we were in-
terested in the relative contribution of other nutritional
factors (i.e. folate, vitamin B12) which may have lead 80 J Health Popul Nutr Mar 2007 VanderJagt DJ et al.
ferritin concentrations of <10 ng/mLcompared to 16.4%
of the non-anaemic women. On the other hand, the inci-
dence of vitamin B12 deficiency was similar in the anae-
mic (7.8%) and non-anaemic groups (10.9%), and the
numbers of subjects with folate deficiency were com-
parable in both the groups (Table 4). Malaria was not
common in women who were classified as anaemic; only
4 of the 44 anaemic women had malaria at the time of
the study. 
These results are similar to those reported for anae-
mic pregnant women in Malawi where van den Broek
and Letsky (15) reported that 23% of anaemic pregnant
women in the southern part of the country were deficient
in iron. One-third of anaemic subjects in that study were
also deficient in vitamin B12, while another one-third
were deficient in folate. Malaria and hookworm infections
were found in 8% and 6% of their subjects respectively. 
The most common screening test for assessing an
individual's vitamin B12 status is the serum concentra-
tion of vitamin B12. Serum vitamin B12 concentrations
have been shown to lack sensitivity in detecting vita-
min B12 deficiency. Assays for vitamin B12, such as
competitive protein-binding immunoassay used in this
study, detect all forms of vitamin B12 in serum, inclu-
ding physiologically-inactive analogues. On the other
hand, excretion of increased amounts of methylmalonic
acid in urine is an early indicator of vitamin B12 defi-
ciency. In a study of elderly individuals in the USA,
10-40% of the subjects had elevated methylmalonic acid
in their urine, while their serum concentration of vita-
min B12 was in the low-normal to normal range (16).
Although the vitamin B12 concentration in the sera of
most women in this study was above 148 pmol/L, the
lower end of the reference range, the serum concentra-
tions we observed in this study, may not reflect the physio-
logically-active amount of vitamin B12 in our subjects
studied. 
The second important finding of the study was the
high percentage of pregnant women with an elevated
serum concentration of homocysteine. The mean homo-
cysteine level (14.1 µmol/L) of pregnant women in
Gombe exceeded the upper limit of normal (i.e. 12.0
µmol/L) (16). Since both folate and vitamin B12 are in-
volved in a single-carbon transfer reaction that converts
homocysteine to methionine, a deficiency of either vita-
min can cause the serum concentration of homocysteine
to be elevated. An elevated homocysteine level during
pregnancy is associated with several adverse outcomes,
including increased habitual spontaneous abortions,
placental abruption, and preeclampsia (17,18). Several 
of our previous studies with adolescent girls and adults
of both genders have shown that moderate hyperhomo-
cysteinaemia was prevalent in Nigerian populations
(12,19,20). We also reported that Nigerian women with
pre-eclampsia had significantly higher serum concentra-
tions of homocysteine than their healthy counterparts
(10.1 vs 8.4 µmol/L), and their homocysteine concentra-
tions were inversely correlated with high-density lipo-
protein concentrations (21). In the present study, serum
concentrations of homocysteine correlated inversely
with both folate and vitamin B12 levels (Figs. 1 and 2).
Of particular interest was the marked increase in the
serum concentrations of homocysteine when the vitamin
B12 levels fell below 250 pmol/L.
Few women in the present study had a serum folate
level indicative of folate deficiency. However, a sub-
optimal vitamin B12 status may elevate serum concen-
tration of folate. In order for folate to be retained by cells,
folate must be converted from its monoglutamate form
to its polyglutamate form. The preferred substrate for the
enzyme that catalyzes this reaction is the tetrahydrofolate
form of folic acid (22). Therefore, in vitamin B12 defi-
ciency, if methyltetrahydrofolate cannot be converted
to tetrahydrofolate, folate will not be retained by the cell.
This condition results in high serum concentrations of
folate in the face of low tissue folate levels. 
There were several limitations in our study. The first
was that the folate status was determined using serum
samples as opposed to determining the red blood cell
concentration of folate which would have provided a
better indication of tissue folate status. Other nutrients,
such as vitamin Aand vitamin B6 that are associated
with anaemia, were not measured. Subjects were also
not tested for hookworm or other parasitic diseases be-
sides malaria__a potential cause of anaemia due to intes-
tinal blood loss. Although a comprehensive assessment
of parasitic infections was not conducted in the study,
such infections are common in pregnant women in
Nigeria. Egwunyenga and co-workers (23) studied more
than 2,000 pregnant women in Plateau State in north-
central Nigeria and found that approximately 40% and
48% of the women were infected with malaria parasites
and intestinal helminths respectively.
We conclude that a high percentage of the pregnant
women we studied in Nigeria were anaemic. The main
contributing factor to anaemia in these women was iron
deficiency. Secondly, suboptimal vitamin B12 status may
contribute to elevated concentrations of homocysteine,
a risk factor for neural tube defects and pre-eclampsia.
Once identified, either or both of these nutritional deficien-
cies could be corrected by food assistance programmes Anaemia in pregnant women in Nigeria 81
or supplementation of vulnerable groups in a population.
An effective method for ensuring widespread correction
of specific nutritional deficiencies could be accomplished
by fortification of foods similar to the fortification with
folate that is common in developed countries for the
prevention of neural tube defects. Because of the impor-
tance of iron stores in maintaining iron balance during
pregnancy, efforts should also be directed to improving
the iron stores of young women prior to pregnancy.  
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